Clinicopathological Factors on Survival after Conversion Surgery for Unresectable Locally Advanced Pancreatic Cancer
The combination of four preoperative prognostic factors may enable risk stratification among patients undergoing CS for UR-LAPC. These findings may help inform treatment sequencing and patient selection, although external validation is needed to confirm their generalizability.
Authors
- Riki Ninomiya (ORCID: https://orcid.org/0000-0003-0787-5646)
- Naoto YAMAMOTO
- Masayuki Otsuka
- Kenichiro Uemura
- Naoki Ozu (ORCID: https://orcid.org/0009-0004-8790-587X)
- Masafumi Imamura (ORCID: https://orcid.org/0000-0001-7669-7666)
- Teiichi SUGIURA
- Yuichi Nagakawa (ORCID: https://orcid.org/0000-0003-1169-8160)
- Masayuki Sho
- Satoshi Yasuda
- Hirofumi Akita
- Manabu Kawai
- Masafumi Nakamura
- Sohei Satoi
- Michiaki Unno
- Hideki Takami
- Yuta Yoshida
- Satoshi Hirano
- Yu Takahashi
- Minako Nagai
Institutions
- Hiroshima University (JP)
- Kansai Medical University (JP)
- Kyushu University (JP)
- Sapporo Medical University (JP)
- Tokyo Medical University (JP)
- Chiba University (JP)
- Wakayama Medical University (JP)
- Tohoku University (JP)
- Hokkaido University (JP)
- Kanagawa Prefectural Hospital Organization (JP)
- Shizuoka Cancer Center (JP)
- Nara Medical University Hospital (JP)
- Osaka International Cancer Institute (JP)
- Social Insurance Saitama Chuo Hospital (JP)
- Japanese Foundation For Cancer Research (JP)
- Kanagawa Cancer Center
- Nagoya University (JP)
- Nara Medical University (JP)
- Saitama Medical University (JP)
- Kindai University (JP)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1097/sla.0000000000007012
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00